Staphylokinase, a fibrin-specific bacterial plasminogen activator

Fibrinolysis

Volumn 10, Issue 3, 1996, Pages 119-126

  Lijnen, H R ^a   Collen, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BACTERIAL PROTEIN; FIBRIN; FIBRINOLYTIC AGENT; HEPARIN; IODINE 125; PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEIN; STAPHYLOKINASE; STREPTOKINASE;

ACUTE HEART INFARCTION; ANIMAL MODEL; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DRUG POTENCY; FIBRINOLYTIC THERAPY; HUMAN; IMMUNOGENICITY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MULTICENTER STUDY; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; THROMBOSIS;

EID: 0029956190     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80022-1     Document Type: Review

References (58)

1. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-24.
2. Lack CH. Staphylokinase: an activator of plasma protease. Nature 1948; 161: 559-60.
3. Lewis JH, Ferguson JH. A proteolytic enzyme system of the blood. III. Activation of dog serum profibrinolysin by staphylokinase. Am J Physiol 1951; 166: 594-603.
4. Winkler KC, DeWaart J, Grootsen C, Zegers BJ M, Tellier NF, Vertegt CD. Lysogenic conversion of staphylococci to loss of beta-toxin. J Gen Microbiol 1965; 39: 321-33.
5. Collen D, Silence K, Demarsin E, De Mol M, Lijnen HR. Isolation and characterization of natural and recombinant staphylokinase. Fibrinolysis 1992; 6: 203-13.
6. Sako T, Tsuchida N. Nucleotide sequence of the staphylokinase gene from Staphylococcus aureus. Nucl Acids Res 1983; 11: 7679-93.
7. Behnke D, Gerlach D. Cloning and expression in Escherichia coli, Bacillus subtilis, and Streptococcus sanguis of a gene for staphylokinase - a bacterial plasminogen activator. Molec Gen Genet 1987; 210: 528-34.
8. Sweet B, McNicol GP, Dougals AS. In vitro studies of staphylokinase. Clin Sci 1965; 29: 375-82.
9. Lewis JH, Shirakawa M. Effects of fibrinolytic agents and heparin on blood coagulation in dogs. Am J Physiol 1964; 207: 1049-52.
10. Lewis JH, Kerber CW, Wilson JH. Effects of fibrinolytic agents and heparin on intravascular clot lysis. Am J Physiol 1964; 207: 1044-48.
11. Kanae K. Fibrinolysis by staphylokinase in vivo. Biol Abstr 1986; 81: AB748.
12. Collen D, Van Hoef B, Schlott B, Hartmann M, Gührs KH, Lijnen HR. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. Fur J Biochem 1993; 216: 307-14.
13. Collen D, Lijnen HR. staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood 1994; 84: 680-6.
14. Collen D, Zhao ZA, Holvoet P, Marynen P. Primary structure and gene structure of staphylokinase. Fibrinolysis 1992; 6: 226-31.
15. Sako T. Overproduction of staphylokinase in Escherichia coli and its characterization. Eur J Biochem 1985; 149: 557-63.
16. Gerlach D, Kraft R, Behnke D. Purification and characterization of the bacterial plasminogen activator staphylokinase, secreted by a recombinant bacillus subtilis. Zbl Bakt Mikr Hyg 1988; 269: 314-22.
17. Damaschun G, Damaschun H, Gast K et al. Physical and conformational properties of staphylokinase in solution. Biochim Biophys Acta 1993; 1161: 244-8.
18. Kowalska-Loth B, Zakrzewski K. The activation by staphylokinase of human plasminogen. Acta Biochim Pol 1975; 22: 327-39.
19. Lijnen HR, Van Hoef B, Collen D. Interaction of staphylokinase with different molecular forms of plasminogen. Eur J Biochem 1993; 211: 91-7.
20. Lijnen HR, De Cock F, Van Hoef B, Schlott B, Collen D. Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem 1994; 224: 143-9.
21. Silence K, Hartmann M, Gührs KH, Gase A, Schlott B, Collen D, Lijnen HR. Structure-function relationships in staphylokinase as revealed by 'clustered charge-to-alanine' mutagenesis. J Biol Chem 1995; 270: 27192-198.
22. Schlott B, Hartmann M, Gührs KH et al. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine 26. Biochim Biophys Acta 1994; 1204: 235-242.
23. Lijnen HR, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O, Collen D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 1991; 266: 11826-832.
24. Collen D, Schlott B, Engelborghs Y et al. On the mechanism of the activation of human plasminogen by recombinant staphylokinase. J Biol Chem 1993; 268: 8284-89.
25. Ready KNN, Markus G. Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. J Biol Chem 1972; 247: 1683-91.
26. Shibata H, Nagaoka M, Sakai M, Sawada H, Watanabe T, Yokokura T. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex. J Biochem 115: 738-42.
27. Sakharov DV, Rijken DC. On the mechanism of the fibrinspecificity of staphylokinase. Fibrinolysis 1996; 9, Suppl (abstract).
28. 2-plasmin inhibitor. Biochem Biophys Res Comm 1989; 162: 830-37.
29. 2-antiplasmin and fibrin. Biochim Biophys Acta 1992; 1118: 144-48.
30. 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex. Thromb Res 1994; 76: 211-20.
31. 2-antiplasmin. J Biol Chem 1993; 268: 9811-16.
32. Okada K, Yuasa H, Hagiya Y, Fukao H, Ueshima S, Matsuo O. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin. Thromb Res 1994; 76: 181-91.
33. 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Blood 1993; 82: 1175-83.
34. Shishido Y, Sakai N, Kaneda N et al. Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis. Biol Pharm Bull 1994; 17: 1595-98.
35. Shishido Y, Matsumoto T, Sakai M et al. Fibrin-specific fibrinolysis induced by recombinant staphylokinase. Biol Pharm Bull 1994; 17: 1060-64.
36. Matsuo O, Okada K, Fukao H et al. Thrombolytic properties of staphylokinase. Blood 1990; 76: 925-29.
37. Lijnen HR, Stassen JM, Collen D. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis. Thromb Haemostas 1995; 73: 845-49.
38. Lijnen HR, Van Hoef B, Vandenbossche L, Collen D. Biochemical properties of natural and recombinant staphylokinase. Fibrinolysis 1992; 6: 214-25.
39. Hauptmann J, Glusa E. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro. Blood Coagul Fibrin 1995; 6: 579-83.
40. Suehiro A, Tsujioka H, Yoshimoto H, Ueda M, Higasa S, Kakishita E. Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation. Thromb Res 1995; 80: 135-42.
41. Sabovic M, Lijnen HR, Keber D, Collen D. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Thromb Haemostas 1989; 62: 1083-87.
42. Lijnen HR, Van Hoef B, Collen D. Interaction of staphylokinase with human platelets. Thromb Haemostas 1995; 73: 472-477.
43. Suehiro A, Oura Y, Ueda M, Kakishita E. Inhibitory effect of staphylokinase on platelet aggregation. Thromb Haemostas 1993; 70: 834-37.
44. Lijnen HR, De Cock F, Matsuo O, Collen D. Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro. Fibrinolysis 1992; 6: 33-7.
45. Lijnen HR, Stassen JM, Vanlinthout I, Fukao H, Okada K, Matsuo O, Collen D. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Thromb Haemostas 1991; 66: 468-73.
46. Collen D, De Cock F, Vanlinthout I, Declerck PJ, Lijnen HR, Stassen JM. Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase. Fibrinolysis 1992; 6: 232-42.
47. Vanderschueren S, Collen D. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models. Thromb Haemostas 1996 (in press).
48. Lijnen HR, Beelen V, Declerck PJ, Collen D. Bio-immunoassay for staphylokinase in blood. Thromb Haemostas 1993; 70: 491-94.
49. Collen D, De Cock F, Stassen JM. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of staphylokinase and streptokinase in baboons. Circulation 1993; 87: 996-1006.
50. Collen D, Van de Werf F. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation 1993; 87: 1850-53.
51. Schlott B, Hartmann M, Gührs KH et al. High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Bio/technology 1994; 12: 185-89.
52. Vanderschueren S, Barrios L, Kerdsinchai P et al. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 1995; 92: 2044-49.
53. Vanderschueren S, Stockx L, Wilms G et al. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation 1995; 92: 2050-57.
54. Vanderschueren S, Collen D ,Van de Werf F. A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis. Thromb Haemostas (submitted).
55. Vanderschueren SMF, Stassen JM, Collen D. On the immunogenicity of recombinant staphylokinase in patients and in animal models. Thromb Haemostas 1994; 72: 297-301.
56. Vanderschueren S, Stassen JM, Collen D. Comparative antigenicity of recombinant wild-type staphylokinase (SakSTAR) and a selected mutant (SakSTAR.M38) in a baboon thrombolysis model. J Cardiovasc Pharmacol (submitted).
57. Collen D, Bernaerts R, Declerck P et al. Recombinant staphylokinase variants with altered immunoreactivity. I. Construction and characterization. Circulation (in press).
58. Collen D, Moreau H, Stockx L, Vanderschueren S. Recombinant staphylokinase variants with altered immunoreactivity. II. Thrombolytic properties and antibody induction. Circulation (in press).